Which of the following is the most appropriate pharmacotherapy recommendation for CR?

RL is a 54 YOM who’s calculated 10-year atherosclerotic cardiovascular disease (ASCVD) risk is 18 %.

Which of the following is the most appropriate pharmacotherapy recommendation for CR?
A . Rosuvastatin 10 mg PO QHS
B . Atorvastatin 80 mg PO QHS
C . Lovastatin 10 mg PO QHS
D . Pravastatin 20 mg PO QHS
E . Atorvastatin 20mg PO QHS

Answer: B

Explanation:

This patient belongs in one of the four statin benefit groups because his estimated 10-year ASCVD risk is over 7.5%. Adults 40 to 75 years of age with LDLCC 70 to 189 mg/dL, with an estimated 10-year ASCVD risk ≥7.5% and without clinical ASCVD or diabetes should receive either a moderate-intensity or high-intensity statin. Since the extent of reducing the risk of ASCVD is proportionally related to the degree of LDL-C reduction, risk could be reduced more so with a high intensity statin. Considering the given options, Atorvastatin 80 mg PO QHS is the best choice.